Search Results - Meester, R.

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Cost effectiveness of surveillance for GI cancers

    Cost effectiveness of surveillance for GI cancers by Omidvari, A., Meester, R., Lansdorp_Vogelaar, Iris

    Published 2016
    Get full text
  2. 2
    Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018

    Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018 by Meester, R., Doubeni, C., Zauber, A., Goede, S., Levin, T., Corley, D., Jemal, A., Lansdorp-Vogelaar, Iris

    Published 2015
    Get full text
  3. 3
    Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis

    Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis by Van Hees, F., Habbema, D., Meester, R., Lansdorp_Vogelaar, Iris, Van Ballegooijen, M., Zauber, A.

    Published 2014
    Get full text
  4. 4
    An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling

    An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling by Kroep, S., Lansdorp_Vogelaar, Iris, Rubenstein, J., de Koning, H., Meester, R., Inadomi, J., van Ballegooijen, M.

    Published 2015
    Get full text
  5. 5
    Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness

    Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness by Van Hees, F., Saini, S., Lansdorp_Vogelaar, Iris, Vijan, S., Meester, R., De Koning, H., Zauber, A., Van Ballegooijen, M.

    Published 2015
    Get full text
  6. 6
    Colorectal cancer deaths attributable to nonuse of screening in the United States

    Colorectal cancer deaths attributable to nonuse of screening in the United States by Meester, R., Doubeni, C., Lansdorp_Vogelaar, Iris, Goede, S., Levin, T., Quinn, V., van Ballegooijen, M., Corley, D., Zauber, A.

    Published 2015
    Get full text
  7. 7
    Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test

    Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test by Meester, R., Zauber, A., Doubeni, C., Jensen, C., Quinn, V., Helfand, M., Dominitz, J., Levin, T., Corley, D., Lansdorp_Vogelaar, Iris

    Published 2016
    Get full text
  8. 8
    Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: A microsimulation model

    Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: A microsimulation model by Meester, R., Doubeni, C., Lansdorp-Vogelaar, Iris, Jensen, C., Van Der Meulen, M., Levin, T., Quinn, V., Schottinger, J., Zauber, A., Corley, D., Van Ballegooijen, M.

    Published 2015
    Get full text

Search Tools: